ClinicalTrials.Veeva

Menu

The Plan and Stand Study: Reducing Sitting Time in Breast Cancer Survivors

University of Wisconsin (UW) logo

University of Wisconsin (UW)

Status

Completed

Conditions

Breast Neoplasms

Treatments

Behavioral: Re-Patterning Sitting Time Group
Behavioral: Usual Care
Behavioral: Reducing Sitting Time Group

Study type

Interventional

Funder types

Other

Identifiers

NCT02510430
2015-0449
UW14101 (Other Identifier)

Details and patient eligibility

About

Excessive sitting time (sedentary time) has been associated with risk of insulin resistance and other factors which may be relevant to breast cancer prognosis. This 8-week study tests different strategies for helping breast cancer survivors to modify their levels of sitting time. Participants will be assigned with equal likelihood to one of three groups (1) overall reduction in sitting time, (2) interruption of sitting time with standing breaks, and (3) usual care.

Enrollment

59 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. diagnosed with Stage 0-III breast cancer. Bilateral or multiple primary breast cancers are permitted.
  2. Completed primary treatment defined as definitive surgery, (neo)adjuvant chemotherapy and/or (neo)adjuvant radiation. Participants still receiving adjuvant endocrine or HER2 targeted therapies are eligible.
  3. Report sitting for ≥8 accumulated waking hours on a typical day,
  4. Willing and able to attend 3 study visits at the UW,
  5. Willing to attempt reduction of sitting time,
  6. Use the internet on a regular basis,
  7. Willing and able to complete study requirements, and
  8. Currently considered postmenopausal (no menstrual periods in past 12 months), even if pre-menopausal at diagnosis.

Exclusion criteria

  1. Evidence of recurrence or metastatic disease,
  2. Unable to move from sitting to standing without difficulty and to walk 1 block.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

59 participants in 3 patient groups, including a placebo group

Reducing Sitting Time Group
Experimental group
Description:
This group will be asked to reduce overall accumulated sitting time by 2 hours per day.
Treatment:
Behavioral: Reducing Sitting Time Group
Re-Patterning Sitting Time Group
Experimental group
Description:
This group will be asked to use standing breaks to interrupt long bouts of sitting time.
Treatment:
Behavioral: Re-Patterning Sitting Time Group
Usual Care
Placebo Comparator group
Description:
This is an attention control group and is not asked to make changes to sitting time.
Treatment:
Behavioral: Usual Care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems